Autologous Stem Cell & Non-Stem Cell Based Therapies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report is Segmented by Type (Autologous Stem Cells and Autologous Non-Stem cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Other Applications), End User (Hospitals, Ambulatory Surgical Centers, and Research Facilities), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecast values are provided in terms of (USD) for all the above segments.

Autologous Stem Cell & Non-Stem Cell Based Therapies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Overview

The global autologous stem cell and non-stem cell-based therapies market is competitive, fragmented, and consists of a few major players. The companies, which include Novartis AG, BrainStorm Cell Limited, Caladrius, Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC, Gilead Sciences Inc., Regeneus Ltd, and US Stem Cell Inc., among others, hold a substantial share in the growth of the market studied.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Leaders

  1. BrainStorm Cell Limited.

  2. Cytori Therapeutics Inc.

  3. Dendreon Pharmaceuticals LLC

  4. Novartis AG

  5. U.S. Stem Cell, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Autologous Stem Cell and Non-Stem Cell Based Therapies Market.png

Autologous Stem Cell & Non-Stem Cell Based Therapies Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?